Genetic and environmental influences on premenstrual symptoms in an Australian twin sample

Treloar, Susan A.; Heath, Andrew C.; Martin, Nicholas G.

doi:10.1017/s0033291701004901

Cited by 79 publications

(43 citation statements)

References 105 publications

(120 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ayrıca sağlık çalışanlarından oluşuyor olması durumun farkındalığına katkıda bulunmakla beraber AÖDB oranının literatürdeki diğer çalışma-lara göre yüksek çıkmasının da nedeni olabilir. Ayrıca çalışma örnekleminde hem ruhsal hastalık öyküsü (%12,7) hem de ruhsal hastalık ve AÖS aile öyküsünün oldukça yüksek olması (sırasıyla %11 ve %51,7) örneklemin AÖDB açısından daha çok risk altın-da olduğunu akla getirebilir [28]. Ayrıca hastane çalışanlarından oluşan bir örneklemde konuyla ilgili sıkıntı yaşayanların araştır-maya katılmada daha istekli olabilecekleri düşünülebilir.…”

Section: Discussionunclassified

Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder

2015

Ann Clin Anal Med

View full text Add to dashboard Cite

Anahtar KelimelerAybaşı Öncesi Sendromu; Tanı; Tarama Abstract Aim: To assess the usefulness of Premenstrual Symptoms Screening Tool (PSST) in detecting Premenstrual Dysphoric Syndrome (PMDD) and Premenstrual Syndrome (PMS) in a Turkish sample. Material and Method: One hundred and eighteen women were included in the study. Participants were menstruating women, between the ages of 18 and 49 years who work in various departments of Diskapi Yildirim Beyazit Teaching and Research Hospital. Sociodemographic data collection form, PSST, and Symptom Check List (SCL-90-R) were given to the participants, filled out by participants and checked out by researchers. Participants were divided into three groups (i.e., women with subthreshold premenstrual symptoms, women with PMDD, and women with PMS) according to the scores they get on the PSST. These groups were compared according to PSST scores and SCL-90-R scores. Results: Internal consistency was excellent (Cronbach α=0.928) for the items of the tool. In this sample, the prevalence of the PMDD and PMS were 15.2 % (n=18) and 32.2 % (n=38) respectively. When we compare the scores on SCL-90-R subscales there were significant differences between the PMDD, PMS, and women with subthreshold groups. Besides there were significant differences for the three groups in terms of percentages of women who reported moderate to severe symptoms on the four items that are essential to PMDD diagnosis. Discussion: Premenstrual Symptoms Screening Tool is a useful tool to detect candidates for PMDD and moderate to severe PMS.

show abstract

Section: Discussionunclassified

Premenstrual Symptom Screening Tool: A Useful Tool for DSM-5 Premenstrual Dysphoric Disorder

2015

Ann Clin Anal Med

View full text Add to dashboard Cite

show abstract

“…Overlap of PMDD with genetic liability for MDD, seasonal affective disorder and personality characteristics has been suggested. 24,25 The diagnosis of PMDD requires the confirmation of luteal-phase impairment of social and/or work functioning that is due to premenstrual symptoms. The functional impairment reported by women with PMDD is similar in severity to the impairment reported in MDD and dysthymic disorder.…”

Section: Epidemiologymentioning

confidence: 99%

Premenstrual Dysphoric Disorder: Burden of Illness and Treatment Update

Pearlstein¹,

Steiner²

2012

FOC

103

View full text Add to dashboard Cite

291Five percent of menstruating women have severe premenstrual symptoms and impairment of functioning defined as premenstrual dysphoric disorder (PMDD). Clinically significant premenstrual symptoms occur in at least an additional 20% of menstruating women. The diagnosis of PMDD should be confirmed by prospective symptom charting over 2 menstrual cycles to confirm the timing of the symptoms and to rule out other diagnoses. The burden of illness of PMDD includes disruption of parenting and partner relationships and decreased productivity in work roles. In addition, women with PMDD have increased use of health care services such as clinician visits and increased use of prescription medications and over-the-counter preparations. The etiology of PMDD is multifactorial. In particular, dysregulation of the serotonin and allopregnanolone systems is implicated. Several effective treatment options exist, including serotonergic antidepressant medications and an oral contraceptive that contains ethinyl estradiol and drosperinone. In addition, other hormones that suppress ovulation, anxiolytics, cognitive therapy, chasteberry and calcium may be helpful.Cinq pour cent des femmes menstruées ont des symptômes prémenstruels sévères et une incapacité du fonctionnement appelée trouble dysphorique prémenstruel (TDPM). Au moins 20 % de femmes menstruées de plus ont des symptômes prémenstruels cliniquement significatifs. Il faut confirmer le diagnostic de TDPM en suivant les symptômes de façon prospective au cours de deux cycles menstruels afin de confirmer le moment de l'apparition des symptômes et d'exclure d'autres diagnostics. Le fardeau morbide imposé par le TDPM comprend la perturbation des relations avec les enfants et le partenaire et une baisse de productivité au travail. Les femmes atteintes de TDPM ont en outre recours davantage aux services de santé comme les visites aux cliniciens et prennent davantage de médicaments d'ordonnance et en vente libre. L'étiologie du TDPM est multifactorielle. La dysrégulation des systèmes de la sérotonine et de l'allopregnanolone en particulier est mise en cause. Il existe plus d'un traitement efficace possible, y compris des antidépresseurs sérotonin-ergiques et un contraceptif oral qui contient de l'éthinyloestradiol et de la drosperinone. D'autres hormones qui bloquent l'ovulation, des anxiolytiques, la thérapie cognitive, le gattilier (Vitex agnus castus) et le calcium peuvent en outre aider. Review Paper Examen critique DiagnosisAbout 80% of women report at least mild premenstrual symptoms, 20%-50% report moderate-to-severe premenstrual symptoms, and about 5% report severe symptoms for several days with impairment of functioning.

show abstract

“…For example, researchers have found that subjective experience and physiological responses towards negative emotion during a menstrual cycle are more influential for neurotic women than they are for women who are low in neuroticism (Wu et al, 2014). Furthermore, it has been observed that women who are high in neuroticism report having more premenstrual symptoms than women who are low in neuroticism do (Treloar et al, 2002;Van Den Akker et al, 1995). Generally, researchers consider neuroticism to be an influential factor regarding emotional experience; indeed, people high in neuroticism are particularly susceptible to negative mood inductions (Thake and Zelenski, 2013).…”

Section: Introductionmentioning

confidence: 99%